Impaired mitochondrial calcium efflux contributes to disease progression in models of Alzheimer's disease.

Jadiya, Pooja; Kolmetzky, Devin W; Tomar, Dhanendra; Di Meco, Antonio; Lombardi, Alyssa A; Lambert, Jonathan P; Luongo, Timothy S; Ludtmann, Marthe H et al. · Nat Commun · 2019

basic_science · Level V

Where this comes from

Abstract

Impairments in neuronal intracellular calcium (<sub>i</sub>Ca<sup>2+</sup>) handling may contribute to Alzheimer's disease (AD) development. Metabolic dysfunction and progressive neuronal loss are associated with AD progression, and mitochondrial calcium (<sub>m</sub>Ca<sup>2+</sup>) signaling is a key regulator of both of these processes. Here, we report remodeling of the <sub>m</sub>Ca<sup>2+</sup> exchange machinery in the prefrontal cortex of individuals with AD. In the 3xTg-AD mouse model impaired <sub>m</sub>Ca<sup>2+</sup> efflux capacity precedes neuropathology. Neuronal deletion of the mitochondrial Na<sup>+</sup>/Ca<sup>2+</sup> exchanger (NCLX, Slc8b1 gene) accelerated memory decline and increased amyloidosis and tau pathology. Further, genetic rescue of neuronal NCLX in 3xTg-AD mice is sufficient to impede AD-associated pathology and memory loss. We show that <sub>m</sub>Ca<sup>2+</sup> overload contributes to AD progression by promoting superoxide generation, metabolic dysfunction and neuronal cell death. These results provide a link between the calcium dysregulation and metabolic dysfunction hypotheses of AD and suggest <sub>m</sub>Ca<sup>2+</sup> exchange as potential therapeutic target in AD.

Medical subject headings